AAV9-MeCP2 gene therapy (Oregon Health Sciences University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAAV9-MeCP2 gene therapy (Oregon Health Sciences University)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionMethyl-CpG-binding protein 2 stimulants
TargetsMethyl-CpG-binding protein 2
Therapy Area/IndicationsRett Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOregon Health And Science University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOregon Health And Science University
Active IndicationsN/A
Inactive IndicationsRett Syndrome

Other Information

ATC CodeN/A
Related LinksN/A